Found 13 matching trials
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer PHASE2 This prospective real-world study aims to evaluate the effectiveness and sa...
Show More Location
Air Force Military Medical University
Learn More & Join Trial
Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma PHASE1 Dear Sir/Madam, We would like to invite you to participate in this clinical...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma NA This project is a prospective, multi-center, multi-cohort exploratory clini...
Show More Location
China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital
Learn More & Join Trial
A Study of Combination Therapy in Patients With Resectable Liver Cancer PHASE2 This is a prospective, single-arm clinical study designed to evaluate the e...
Show More Location
Affiliated Hospital of Guangdong Medical University
Learn More & Join Trial
A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC PHASE2 Southeast Asia and China have the highest incidence of intrahepatic cholang...
Show More Location
Tianjin Cancer Hospital Airport Hospital
Learn More & Join Trial
HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure PHASE2 For patients with advanced liver cancer who have progressed after first-lin...
Show More Location
Multiple Locations
Learn More & Join Trial
HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer PHASE2 This is a single-arm, exploratory, phase II trial to evaluate the efficacy ...
Show More Location
Multiple Locations
Learn More & Join Trial
Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC PHASE2 The goal of this clinical trial is to explore the efficacy and safety of co...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma PHASE2 The purpose of this study is to evaluate the efficacy and safety of Adabrel...
Show More Location
Gansu Province Cancer Hospital
Learn More & Join Trial
Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial PHASE2 his is a single-arm, phase II clinical study evaluating the efficacy and sa...
Show More Location
Multiple Locations
Learn More & Join Trial